![Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy | British Journal of Cancer Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-018-0310-8/MediaObjects/41416_2018_310_Fig1_HTML.png)
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy | British Journal of Cancer
![Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial - The Lancet Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2001010455/2003789866/gr1.gif)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial - The Lancet
![Sticker porte citation ici c'est ma chambre, tu rentres pas – Stickers STICKERS CITATIONS Français - Ambiance-sticker Sticker porte citation ici c'est ma chambre, tu rentres pas – Stickers STICKERS CITATIONS Français - Ambiance-sticker](https://www.ambiance-sticker.com/images/Image/sticker-porte-citation-ici-c-est-ma-chambre-tu-rentres-pas-ambiance-sticker-KC_2863.png)
Sticker porte citation ici c'est ma chambre, tu rentres pas – Stickers STICKERS CITATIONS Français - Ambiance-sticker
![Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial - The Lancet Oncology Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/8d8bf3a6-fe30-49f1-8ced-922c620e132a/gr1.gif)